Blue Owl Capital presents a high-yield opportunity with a nearly 10% dividend despite concerns about its credit business. IBM receives a bullish catalyst as the US government proposes a $1 billion equity stake to support its quantum computing roadmap, highlighting strong growth potential in this emerging market. Additionally, Quantum Computing is viewed as a speculative buy due to its strong cash position and accelerating revenue in a market expected to grow at a 35% CAGR. Hims & Hers Health is rated Strong Buy, driven by its partnership with Novo Nordisk, international expansion, and focus on platform-driven healthcare growth.
IBM shares increased by 5% following President Trump's acknowledgment that selling IBM stock was a mistake. Trump praised IBM and its CEO, Arvind Krishna, calling him a "great man" during a White House event where he signed two executive orders to su...
President Donald Trump signed executive orders to support a powerful U.S.-made quantum computer by 2028, aligning with a $2 billion quantum initiative led by the U.S. Commerce Department. IBM is the largest beneficiary, receiving about $1 billion to ...
President Trump signed two executive orders to accelerate quantum computing development and prepare for security risks from quantum technology. This federal push includes billions in funding, benefiting companies like IBM, D-Wave, Rigetti, and IonQ, ...
Stock futures fell after a mixed Monday where tech stocks dragged Nasdaq and S&P 500 down, while Dow and Russell 2000 gained. Treasury yields surged following Bank of America's forecast of three 25-basis-point Fed rate hikes in late 2026, signaling p...
Oracle reduced its workforce by nearly 13%, cutting 21,000 jobs to 141,000 employees as of May 2026, citing AI technology deployment as a key factor. The company spent $1.8 billion on restructuring costs, a significant increase from the previous year...
